Zhu Y et al. demonstrated that MBD2 was a protective signature against bladder carcinoma according to the RNA data from the peripheral blood lymphocytes of 98 bladder cancer patients and 135 frequency-matched control patients (Zhu et al., 2004). This evidence concerns the gene MBD2 and urinary bladder cancer.